Zydus gains final USFDA approval for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg Read more
Gilead’s Livdelzi wins FDA approval, can challenge Ocaliva dominance in primary biliary cholangitis market Read more
J&J’s EGFR-mutated advanced lung cancer treatment: amivantamab-vmjw plus lazertinib gains FDA approval Read more